Remie, Lianne B.
van Loenen, Mark R.
van Trijp, Mara P.H.
de Lange, Ilke G.S.
Vermeiren, Yannick
Mes, Jurriaan J.
Puts, Nicolaas A.
Oosterman, Joukje M.
Aarts, Esther
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (MOCIA 17611)
Article History
Received: 10 December 2025
Accepted: 13 March 2026
First Online: 9 April 2026
Declarations
:
: The HELI study was conducted in compliance with the Declaration of Helsinki for research involving human participants and the Medical Research Involving Human Subjects Act (WMO; ‘Wet Medisch-wetenschappelijk Onderzoek met mensen’). The complete procedure was approved by the local Ethics Committee (METC Oost-Nederland, NL78263.091.21) on December 2nd 2021 and registered in the Clinical Trial Register (ClinicalTrials.gov ID: NCT05777863). Written informed consent was obtained from each participant during the first study visit.
: Not applicable.
: The authors declare no competing interests.